OAKTREE CAPITAL MANAGEMENT LP - INTERCEPT PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 24 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
OAKTREE CAPITAL MANAGEMENT LP ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$9,600,523
-32.6%
9,506,000
-33.2%
0.13%
-19.7%
Q1 2023$14,236,510
+34.7%
14,234,000
+33.3%
0.16%
+41.4%
Q4 2022$10,570,516
+9.1%
10,677,000
+7.2%
0.11%
+4.7%
Q3 2022$9,690,000
+43.3%
9,964,000
+43.0%
0.11%
+34.2%
Q2 2022$6,760,000
+6.7%
6,970,000
+4.7%
0.08%
+19.7%
Q1 2022$6,338,000
+3.1%
6,655,000
+2.5%
0.07%
-1.5%
Q4 2021$6,149,000
-58.5%
6,494,000
-60.5%
0.07%
-66.3%
Q2 2021$14,816,000
-15.6%
16,435,000
-23.3%
0.20%
-18.4%
Q1 2021$17,550,000
+16.4%
21,435,000
+10.3%
0.24%
-6.2%
Q4 2020$15,079,000
-31.2%
19,435,000
-28.3%
0.26%
-45.5%
Q3 2020$21,933,000
+8.7%
27,113,000
+1.8%
0.48%
+6.5%
Q2 2020$20,172,000
+282.9%
26,629,000
+317.0%
0.45%
+202.7%
Q1 2020$5,268,000
+35.0%
6,386,000
+65.4%
0.15%
+100.0%
Q4 2019$3,902,000
-22.6%
3,861,000
-33.8%
0.07%
-25.3%
Q3 2019$5,041,000
-5.6%
5,828,000
-2.2%
0.10%
-1.0%
Q2 2019$5,342,000
-57.7%
5,959,000
-53.0%
0.10%
-58.3%
Q1 2019$12,621,000
-78.9%
12,689,000
-80.3%
0.24%
-55.9%
Q4 2018$59,704,000
+35.7%
64,452,000
+48.8%
0.54%
-8.1%
Q3 2018$43,995,000
+44.9%
43,316,000
+25.7%
0.59%
+39.6%
Q2 2018$30,352,000
+3.0%
34,470,000
-5.7%
0.42%
-9.4%
Q1 2018$29,477,000
+29.7%
36,560,000
+28.7%
0.47%
+31.5%
Q4 2017$22,732,000
+131.8%
28,415,000
+184.2%
0.36%
+122.5%
Q2 2017$9,807,000
-53.8%
10,000,000
-47.1%
0.16%
-42.0%
Q3 2016$21,245,000–18,900,000–0.28%–
 Download
Other shareholders

There were no reported owners of INTERCEPT PHARMACEUTICALS IN in Q1 2022.

NameSharesValueWeighting ↓
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders